Equity Investment Corp’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$145M Sell
1,681,360
-62,944
-4% -$5.52M 2.76% 11
2026
Q1
$158M Buy
1,744,304
+410,858
+31% +$37.7M 3.09% 5
2025
Q4
$120M Sell
1,333,446
-108,509
-8% -$10.3M 2.42% 12
2025
Q3
$142M Sell
1,441,955
-11,249
-0.8% -$1.11M 2.98% 6
2025
Q2
$133M Buy
1,453,204
+414,856
+40% +$40.1M 2.9% 8
2025
Q1
$118M Buy
1,038,348
+17,286
+2% +$1.85M 2.63% 15
2024
Q4
$108M Buy
1,021,062
+371,653
+57% +$39.9M 2.53% 16
2024
Q3
$70.1M Buy
+649,409
New +$70.9M 1.63% 33

Other funds holding ZBH

Equity Investment Corp's ZBH Position: Q2 2026 in Review

Equity Investment Corp reduced its Zimmer Biomet (ZBH) stake by 3.6% in Q2 2026, selling an estimated $5.52M and leaving 1,681,360 shares worth $145M. The position accounts for 2.76% of the portfolio, ranked #11.

Equity Investment Corp first reported a position in ZBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $158M in Q1 2026. 907 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Equity Investment Corp held 1,681,360 shares of Zimmer Biomet worth $145M as of Q2 2026.
  • Equity Investment Corp sold 62,944 Zimmer Biomet shares in Q2 2026, an estimated $5.52M.
  • Zimmer Biomet made up 2.76% of Equity Investment Corp's portfolio in Q2 2026, its #11 holding.
  • Equity Investment Corp first reported a position in Zimmer Biomet in Q3 2024 and has held it in 8 quarters since.
  • Equity Investment Corp's Zimmer Biomet position peaked at $158M in Q1 2026.
  • 907 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Equity Investment Corp's 13F filing for Q2 2026, filed 7 Aug 2026.